He is working on shingles rather than on the coronavirus pandemic.
HE IS NOT ROWING IN A DIRECTION AGAINST THE VIRUS.
"Despite the press releases and media appearances on coronavirus, Diwan said the company is focused on a different disease.
“Our priority remains our lead drug candidate for the treatment of shingles rash. ... We have limited resources that we must judiciously prioritize towards making our drug development programs successful,” he said in that email. “We are performing activities for the coronavirus project solely from a humanitarian perspective.”